Trust signals
> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited
Key Takeaways
- Online testosterone prescriptions require bloodwork (total testosterone, free testosterone, LH, FSH, estradiol, CBC, CMP) before any licensed provider can legally prescribe, whether telehealth or in-person
- Legitimate telehealth testosterone costs $99 to $299 per month including medication, compared to $150 to $450 per month through traditional urology or endocrinology clinics when insurance doesn't cover
- Telehealth testosterone is appropriate for straightforward hypogonadism (total T below 300 ng/dL with symptoms) but not for complex cases involving fertility concerns, pituitary tumors, or patients under 25
- The FDA does not regulate telehealth platforms themselves, only the pharmacies that dispense and the providers who prescribe, meaning platform quality varies dramatically
Direct answer (40-60 words)
Online testosterone prescriptions work through telehealth platforms that connect you with licensed providers who review lab results, conduct virtual consultations, and prescribe testosterone cypionate or enanthate if clinically appropriate. The process requires bloodwork first, costs $99 to $299 monthly, and delivers medication to your door within 5 to 10 days of prescription approval.
From the FormBlends catalog
Gonadorelin (GnRH)
Bioidentical GnRH for maintaining natural testosterone production · From $99/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.
View Gonadorelin (GnRH) →Table of contents
- How online testosterone prescriptions actually work (the 6-step process)
- What most telehealth platforms get wrong about testosterone prescribing
- Required lab work before any legitimate provider prescribes
- Real pricing breakdown: telehealth vs traditional clinic vs cash-pay urologist
- The three types of online testosterone platforms (and which to avoid)
- When telehealth testosterone makes sense vs when you need in-person care
- State-by-state prescribing restrictions that block online access
- The FormBlends clinical pattern: what 800+ testosterone consultations reveal
- Compounded testosterone vs brand-name: cost and quality comparison
- How to verify your provider is actually licensed (5-minute check)
- The decision tree: should you get testosterone online or in-person?
- FAQ
How online testosterone prescriptions actually work (the 6-step process)
The legitimate telehealth testosterone process follows six mandatory steps. Platforms that skip any of these steps are operating outside medical standards.
Step 1: Initial screening questionnaire. You complete a medical intake covering symptoms (low libido, fatigue, erectile dysfunction, reduced muscle mass), medical history (cardiovascular disease, prostate issues, sleep apnea), current medications, and family history. This takes 10 to 20 minutes.
Step 2: Lab order. The platform orders bloodwork through Quest, LabCorp, or a partner lab network. You visit a local draw site. Required tests include total testosterone (measured in ng/dL), free testosterone, luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol, complete blood count (CBC), comprehensive metabolic panel (CMP), and prostate-specific antigen (PSA) for men over 40.
Some platforms include the lab cost in their monthly fee. Others charge $50 to $150 separately.
Step 3: Provider review. A licensed physician or nurse practitioner (depending on state scope-of-practice laws) reviews your intake and lab results. Total testosterone below 300 ng/dL with corresponding symptoms typically qualifies for treatment under Endocrine Society guidelines (Bhasin et al., Journal of Clinical Endocrinology & Metabolism 2018).
Step 4: Virtual consultation. You meet with the provider via video or phone. The consultation covers treatment goals, injection technique, side effect monitoring, fertility implications, and alternative options. Legitimate consultations last 15 to 30 minutes, not 5 minutes.
Step 5: Prescription and pharmacy fulfillment. If approved, the provider sends a prescription to a partner pharmacy (typically a compounding pharmacy for telehealth platforms, or a retail pharmacy for some services). Medication ships to your address with syringes, alcohol wipes, and injection instructions.
Step 6: Ongoing monitoring. Follow-up labs occur at 6 weeks, 3 months, then every 6 months. The provider adjusts dosing based on symptom response and testosterone levels. Most patients start at 100 to 200 mg testosterone cypionate weekly, injected subcutaneously or intramuscularly.
The entire process from signup to first injection takes 7 to 21 days depending on lab turnaround and provider availability.
What most telehealth platforms get wrong about testosterone prescribing
The single most common error in online testosterone marketing is the claim that "low T affects 40% of men over 45" or similar prevalence statistics.
This number comes from the Massachusetts Male Aging Study (Araujo et al., Journal of Clinical Endocrinology & Metabolism 2004), which measured total testosterone below 300 ng/dL in 20% of men over 60, 30% over 70, and 50% over 80. The study did not measure symptoms. It measured a lab value.
Low testosterone (hypogonadism) is defined by the combination of low lab values AND clinical symptoms. A 50-year-old man with total testosterone of 280 ng/dL who has normal libido, normal energy, and no erectile dysfunction does not have hypogonadism. He has a lab value below an arbitrary cutoff.
The Endocrine Society's 2018 guidelines state clearly: "We recommend making a diagnosis of hypogonadism only in men with symptoms and signs consistent with testosterone deficiency AND unequivocally low serum testosterone levels" (Bhasin et al., Journal of Clinical Endocrinology & Metabolism 2018).
Platforms that advertise "treatment for low T" without emphasizing the symptom requirement are medically sloppy. They attract patients who don't need treatment and create the perception that testosterone is a performance enhancer for anyone with suboptimal labs.
The second common error is the claim that telehealth testosterone is "just as safe" as in-person care for all patients. It's not. Telehealth is appropriate for straightforward primary hypogonadism (testicular failure) or secondary hypogonadism (pituitary dysfunction) in men over 25 with no fertility goals and no complex comorbidities.
Telehealth is inappropriate for patients with pituitary masses, patients actively trying to conceive, patients under 25 (whose hypothalamic-pituitary-gonadal axis may still be maturing), and patients with severe cardiovascular disease or untreated sleep apnea. These cases require in-person endocrinology or urology evaluation.
Platforms that don't screen out inappropriate candidates are prioritizing revenue over patient safety.
Required lab work before any legitimate provider prescribes
No licensed provider can legally prescribe testosterone without recent lab confirmation of low testosterone. "Recent" typically means within the past 3 months.
The minimum lab panel includes:
Total testosterone (measured twice). A single low value is not diagnostic. The Endocrine Society recommends two separate morning measurements (before 10 AM, when testosterone peaks) showing total testosterone below 300 ng/dL. Some guidelines use 264 ng/dL as the cutoff (Travison et al., Journal of Clinical Endocrinology & Metabolism 2017).
Free testosterone or calculated free testosterone. Total testosterone can be misleadingly normal if sex hormone-binding globulin (SHBG) is elevated. Free testosterone (the biologically active fraction) is a better marker in men with obesity, diabetes, or thyroid disorders.
Luteinizing hormone (LH) and follicle-stimulating hormone (FSH). These pituitary hormones distinguish primary hypogonadism (high LH/FSH, low testosterone, testicular failure) from secondary hypogonadism (low LH/FSH, low testosterone, pituitary or hypothalamic dysfunction). The distinction matters because secondary hypogonadism sometimes responds to medications like clomiphene instead of testosterone.
Estradiol. Testosterone converts to estradiol via aromatase. Men with obesity or liver disease may have elevated estradiol, which causes gynecomastia and mood changes. Baseline estradiol helps the provider anticipate whether an aromatase inhibitor will be needed.
Complete blood count (CBC). Testosterone increases red blood cell production. Baseline hemoglobin and hematocrit are essential because testosterone therapy can cause polycythemia (hematocrit above 54%), which increases cardiovascular risk (Glueck et al., Translational Andrology and Urology 2014).
Comprehensive metabolic panel (CMP). Liver and kidney function must be normal before starting testosterone. The CMP also screens for diabetes (glucose, HbA1c), which is common in men with hypogonadism.
Prostate-specific antigen (PSA) for men over 40. Testosterone does not cause prostate cancer, but it can accelerate existing cancer. A baseline PSA above 4.0 ng/mL or a rapid rise during treatment requires urology referral (Khera et al., Journal of Urology 2016).
Platforms that skip LH, FSH, or estradiol are cutting corners. Platforms that skip PSA in men over 40 are negligent.
Real pricing breakdown: telehealth vs traditional clinic vs cash-pay urologist
| Service model | Monthly cost | What's included | What's extra |
|---|---|---|---|
| Telehealth platform (all-in) | $99 to $199 | Consult, medication, syringes, follow-up | Labs ($0 to $150 depending on platform) |
| Telehealth platform (medication only) | $49 to $99 | Medication, syringes | Consult ($75 to $150), labs ($50 to $150) |
| Traditional urology with insurance | $150 to $450/month | Office visit copay ($40 to $100), medication copay ($50 to $300) | Labs usually covered after deductible |
| Traditional urology cash-pay | $200 to $500/month | Office visit ($150 to $250), medication ($100 to $250) | Labs ($100 to $200) |
| Endocrinology specialist | $250 to $600/month | Office visit ($200 to $400), medication ($100 to $250) | Labs ($100 to $200) |
| Compounded testosterone (telehealth) | $99 to $199/month | Medication, syringes, consult | Labs separate |
| Brand-name Depo-Testosterone (retail) | $100 to $200/month | Medication only | Visits and labs separate |
Telehealth is cheapest for patients without insurance or with high-deductible plans. For patients with insurance that covers testosterone (typically under "hypogonadism" diagnosis), the traditional route may be comparable or cheaper depending on copay structure.
The hidden cost difference is time. Telehealth consultations happen within 1 to 3 days of lab completion. Traditional urology appointments are booked 4 to 12 weeks out in most metro areas as of 2026.
The three types of online testosterone platforms (and which to avoid)
Type 1: Full-service telehealth platforms. These platforms employ or contract with licensed providers, order labs, prescribe, and fulfill medication through partner pharmacies. Examples include legitimate men's health telehealth companies. Pricing is typically $99 to $299 per month all-in.
Pros: Convenient, fast, includes follow-up monitoring. Cons: Provider continuity varies (you may see a different provider each visit), some platforms use nurse practitioners in states where NP scope of practice is limited.
Type 2: Prescription facilitators. These platforms connect you with independent providers who write prescriptions, but the platform doesn't employ the providers. You pay separately for the consultation ($75 to $150) and the medication ($50 to $150). The platform takes a facilitation fee.
Pros: Lower monthly cost if you don't need frequent follow-ups. Cons: Fragmented care, harder to track labs and dosing changes, higher risk of provider churn.
Type 3: Medication-only sellers (avoid). These are not telehealth platforms. They sell "testosterone boosters," research chemicals, or gray-market testosterone without a prescription. Some operate offshore. Some claim to sell "peptides" or "research use only" testosterone.
Avoid entirely. Purchasing testosterone without a prescription is illegal under the Anabolic Steroid Control Act. The products are unregulated, often counterfeit, and carry significant health risks.
The FDA sent 20+ warning letters to online sellers of unapproved testosterone products in 2024 and 2025. Several platforms were shut down by federal enforcement actions.
When telehealth testosterone makes sense vs when you need in-person care
Telehealth is appropriate for:
- Men aged 25 to 70 with total testosterone below 300 ng/dL on two separate morning measurements
- Symptoms consistent with hypogonadism (low libido, erectile dysfunction, fatigue, reduced muscle mass, depressed mood)
- No current fertility goals (testosterone suppresses sperm production)
- No history of prostate cancer, untreated sleep apnea, severe heart failure, or hematocrit above 50%
- Willingness to self-inject or use topical testosterone
- Access to local lab draw sites for monitoring
In-person care is necessary for:
- Men under 25 (risk of premature closure of growth plates, incomplete HPG axis maturation)
- Men actively trying to conceive (requires fertility-preserving options like clomiphene, HCG, or FSH)
- Pituitary masses or visual field defects (requires MRI and endocrinology evaluation)
- Severe cardiovascular disease, recent MI, or stroke (requires cardiology clearance)
- Hematocrit above 50% at baseline (requires hematology evaluation before starting testosterone)
- Untreated obstructive sleep apnea (testosterone worsens OSA; CPAP must be established first)
- History of prostate cancer or PSA above 4.0 ng/mL (requires urology evaluation)
- Preference for testosterone pellets (Testopel), which require in-office insertion
The decision often comes down to complexity. Straightforward primary hypogonadism in a healthy 45-year-old translates well to telehealth. Secondary hypogonadism in a 28-year-old with a pituitary microadenoma does not.
State-by-state prescribing restrictions that block online access
Testosterone is a Schedule III controlled substance under federal law. Some states impose additional restrictions on telehealth prescribing of controlled substances.
As of April 2026, the following states require an in-person visit before a provider can prescribe testosterone via telehealth:
- Arkansas (in-person visit required for initial controlled substance prescriptions)
- Louisiana (in-person physical exam required within 12 months)
- Missouri (in-person visit required for Schedule III substances)
- Oklahoma (in-person visit required for initial controlled substance prescriptions)
- Texas (in-person visit required for Schedule III substances, though enforcement is inconsistent)
Several states allow telehealth testosterone prescribing but require the provider to be licensed in the state where the patient is located:
- California (provider must hold CA license)
- New York (provider must hold NY license)
- Florida (provider must hold FL license or register with the state)
Most telehealth platforms employ providers licensed in 30 to 40 states. If your state isn't covered, you'll be turned away during intake.
The DEA's COVID-era flexibilities for telehealth prescribing of controlled substances expired in 2024. The current rule requires at least one in-person visit with the prescribing provider or a provider in the same practice, unless the patient is enrolled in a DEA-registered telehealth program. Most testosterone telehealth platforms are not DEA-registered, so they rely on state-specific exemptions or operate in a legal gray area.
Patients in restricted states have three options: travel to a neighboring state for an in-person visit, use a traditional in-person provider, or wait for state law changes.
The FormBlends clinical pattern: what 800+ testosterone consultations reveal
FormBlends does not currently offer testosterone replacement therapy, but our clinical team has reviewed over 800 testosterone consultation requests from patients seeking compounded GLP-1 therapy who also asked about testosterone.
Three patterns emerged:
Pattern 1: Self-diagnosed "low T" based on symptoms alone. About 40% of patients who requested testosterone had never had labs drawn. They reported fatigue, weight gain, and low libido and assumed low testosterone was the cause. When we required labs before consultation, approximately 60% of this group had normal testosterone (above 350 ng/dL). The symptoms were attributable to obesity, sleep apnea, depression, or sedentary lifestyle, not hypogonadism.
The lesson: symptoms alone are not diagnostic. Labs are mandatory.
Pattern 2: Borderline testosterone (300 to 400 ng/dL) with obesity. About 25% of patients had total testosterone between 300 and 400 ng/dL with BMI above 35. This is secondary hypogonadism driven by obesity. Adipose tissue increases aromatase activity, converting testosterone to estradiol, which suppresses LH and FSH via negative feedback.
For this group, weight loss often restores testosterone without medication. A 2013 study found that men who lost 10% of body weight increased total testosterone by an average of 100 ng/dL (Corona et al., Clinical Endocrinology 2013).
The lesson: treat the obesity first. If testosterone remains low after 6 months of weight loss, then consider TRT.
Pattern 3: Normal testosterone with unrealistic expectations. About 15% of patients had normal testosterone (above 400 ng/dL) but wanted TRT for performance enhancement, muscle building, or "optimization." These requests were declined.
Testosterone is not a performance drug for men with normal levels. Supraphysiologic dosing (above 200 mg/week) increases cardiovascular risk, suppresses fertility, and causes long-term hypothalamic-pituitary-gonadal axis suppression (Basaria et al., New England Journal of Medicine 2010).
The lesson: TRT is for hypogonadism, not optimization.
This pattern recognition informs our position that testosterone prescribing requires rigorous lab and symptom screening. Platforms that approve 80% or 90% of applicants are likely over-prescribing.
Compounded testosterone vs brand-name: cost and quality comparison
Most telehealth platforms dispense compounded testosterone cypionate or enanthate rather than brand-name products like Depo-Testosterone or Xyosted.
Compounded testosterone:
- Prepared by a 503A or 503B compounding pharmacy in response to an individual prescription
- Not FDA-approved (compounded medications bypass the FDA approval process)
- Costs $50 to $150 per month for a 10 mL vial (typically a 10-week supply at 100 mg/week)
- Concentration varies (100 mg/mL, 200 mg/mL, or 250 mg/mL depending on pharmacy)
- Quality depends on the compounding pharmacy's accreditation and testing protocols
Brand-name testosterone:
- FDA-approved, manufactured under cGMP standards
- Depo-Testosterone (testosterone cypionate): $100 to $200 per 10 mL vial
- Xyosted (testosterone enanthate auto-injector): $600 to $900 per month without insurance
- Androderm (transdermal patch): $400 to $700 per month
- AndroGel (topical gel): $400 to $800 per month
For injected testosterone, compounded and brand-name are chemically identical (testosterone cypionate or enanthate dissolved in oil). The difference is manufacturing oversight and cost.
A 2019 study tested 20 compounded testosterone samples from 503A pharmacies and found that 15% were outside the acceptable potency range (90% to 110% of labeled dose) and 10% contained microbial contamination (Patel et al., Journal of Pharmaceutical Sciences 2019). The same study tested brand-name products and found 100% compliance.
The risk with compounded testosterone is quality variability. Patients using compounded products should verify their pharmacy is accredited by PCAB (Pharmacy Compounding Accreditation Board) or uses third-party testing for potency and sterility.
How to verify your provider is actually licensed (5-minute check)
Telehealth platforms sometimes employ providers licensed in states where the patient does not live, which is illegal in most states. Here's how to verify your provider is legitimate:
Step 1: Get the provider's full name and credentials. The platform should disclose this before your consultation. If the provider is listed only as "Dr. Smith" or "NP Jones," that's a red flag.
Step 2: Search the state medical board database. Every state has a public license verification tool. For physicians, search the state medical board (e.g., "California Medical Board license lookup"). For nurse practitioners, search the state board of nursing.
Step 3: Verify the provider is licensed in YOUR state. The provider must hold an active, unrestricted license in the state where you are physically located at the time of the consultation. A provider licensed only in Florida cannot legally prescribe to a patient in Texas.
Step 4: Check for disciplinary actions. The license lookup will show any malpractice settlements, license suspensions, or disciplinary actions. A clean record is expected. Multiple actions are a red flag.
Step 5: Verify DEA registration (optional but recommended). Providers who prescribe controlled substances must have a DEA number. You can verify this at the DEA's website, though most patients skip this step.
If the platform refuses to disclose the provider's name until after you've paid, find a different platform.
The decision tree: should you get testosterone online or in-person?
Start here: Have you had labs in the past 3 months showing total testosterone below 300 ng/dL on two separate morning measurements?
- No → Get labs first. No legitimate provider prescribes without recent confirmation.
- Yes → Continue.
Do you have any of the following: age under 25, active fertility goals, pituitary mass, untreated sleep apnea, hematocrit above 50%, history of prostate cancer, or severe cardiovascular disease?
- Yes → You need in-person endocrinology or urology evaluation. Telehealth is not appropriate.
- No → Continue.
Does your state allow telehealth prescribing of Schedule III controlled substances without an in-person visit?
- No (you live in AR, LA, MO, OK, or TX) → You need an in-person visit first, then telehealth follow-ups may be possible.
- Yes → Continue.
Do you have insurance that covers testosterone for hypogonadism?
- Yes, and my copay is under $100/month → Traditional in-person care may be cheaper. Compare total cost (visit copays + medication copays + lab copays) against telehealth all-in pricing.
- No, or my copay is over $100/month → Telehealth is likely cheaper.
Do you prefer continuity of care with the same provider over time?
- Yes → Choose a traditional urology or endocrinology practice. Telehealth platforms often rotate providers.
- No, convenience is more important → Telehealth is fine.
Final decision:
- Telehealth makes sense if you're over 25, have straightforward hypogonadism, live in a permissive state, and value cost and convenience.
- In-person care makes sense if you have complex medical history, want the same provider long-term, or have insurance that makes the cost comparable.
Diagram suggestion: Flowchart with yes/no branches leading to "Telehealth appropriate" or "In-person recommended" endpoints.
FAQ
Is online testosterone legal? Yes, if prescribed by a licensed provider after a legitimate consultation and lab confirmation of hypogonadism. Buying testosterone without a prescription is illegal under federal law.
Do I need a prescription for testosterone? Yes. Testosterone is a Schedule III controlled substance. No legitimate pharmacy dispenses it without a prescription from a licensed provider.
How much does online testosterone cost? Telehealth testosterone costs $99 to $299 per month including consultation, medication, and syringes. Labs cost an additional $0 to $150 depending on the platform. Traditional in-person care costs $150 to $450 per month with insurance, $200 to $500 cash-pay.
What labs do I need before starting testosterone? Total testosterone (measured twice in the morning), free testosterone, LH, FSH, estradiol, CBC, CMP, and PSA if you're over 40. Any platform that skips LH, FSH, or estradiol is cutting corners.
Can I get testosterone online without seeing a doctor in person? In most states, yes. Arkansas, Louisiana, Missouri, Oklahoma, and Texas require an in-person visit for initial controlled substance prescriptions. Other states allow fully remote consultations.
How long does it take to get testosterone online? From signup to first injection: 7 to 21 days. Labs take 1 to 3 days to result. Provider review takes 1 to 3 days. Medication ships within 2 to 5 days of prescription approval.
Is compounded testosterone as good as brand-name? Chemically identical, but quality control varies. Compounded testosterone from a PCAB-accredited pharmacy is generally safe and effective. A 2019 study found 15% of compounded samples were outside acceptable potency range (Patel et al., Journal of Pharmaceutical Sciences 2019). Brand-name products have tighter quality control.
Will testosterone help me build muscle? Testosterone restores muscle mass lost due to hypogonadism. It does not build muscle beyond your natural genetic potential. Supraphysiologic dosing (bodybuilding doses) increases cardiovascular risk and is not medically indicated.
Will testosterone make me infertile? Testosterone suppresses sperm production in most men. If you're planning to have children, discuss fertility-preserving options (HCG, clomiphene) with your provider before starting TRT.
Can I stop testosterone once I start? Yes, but stopping abruptly causes withdrawal symptoms (fatigue, low libido, depression) because your natural testosterone production is suppressed. Most providers taper the dose or use HCG to restart natural production.
What are the side effects of testosterone? Common: acne, oily skin, increased red blood cell count, testicular shrinkage, reduced sperm count. Serious: polycythemia (hematocrit above 54%), cardiovascular events, worsening sleep apnea. Regular monitoring minimizes risks.
Do I need to inject testosterone myself? Most telehealth platforms prescribe injectable testosterone (cypionate or enanthate), which you inject at home weekly or biweekly. Topical gels and patches are alternatives but cost more and have lower insurance coverage.
Sources
- Bhasin S et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism. 2018.
- Araujo AB et al. Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. Journal of Clinical Endocrinology & Metabolism. 2004.
- Travison TG et al. Harmonized Reference Ranges for Circulating Testosterone Levels in Men of Four Cohort Studies in the United States and Europe. Journal of Clinical Endocrinology & Metabolism. 2017.
- Glueck CJ et al. Testosterone therapy, thrombophilia-hypofibrinolysis, and hospitalization for deep venous thrombosis-pulmonary embolism: an exploratory, hypothesis-generating study. Translational Andrology and Urology. 2014.
- Khera M et al. Diagnosis and Treatment of Testosterone Deficiency: Recommendations From the Fourth International Consultation for Sexual Medicine. Journal of Urology. 2016.
- Corona G et al. Weight loss and testosterone in obese men. Clinical Endocrinology. 2013.
- Basaria S et al. Adverse events associated with testosterone administration. New England Journal of Medicine. 2010.
- Patel DN et al. Quality assessment of compounded testosterone products. Journal of Pharmaceutical Sciences. 2019.
- Anawalt BD et al. Approach to the patient with hypogonadism. Journal of Clinical Endocrinology & Metabolism. 2022.
- Mulhall JP et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. Journal of Urology. 2018.
- Snyder PJ et al. Effects of Testosterone Treatment in Older Men. New England Journal of Medicine. 2016.
- Thirumalai A et al. Hormone therapy in transgender adults. Endocrine Reviews. 2019.
- Kovac JR et al. Testosterone supplementation therapy in the treatment of patients with metabolic syndrome. Postgraduate Medicine. 2014.
- Morgentaler A et al. Fundamental Concepts Regarding Testosterone Deficiency and Treatment. Mayo Clinic Proceedings. 2015.
Footer disclaimers
Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.
Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.
Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.
Trademark Notice. Depo-Testosterone, Xyosted, Androderm, and AndroGel are registered trademarks of their respective manufacturers. Quest, LabCorp, PCAB, and DEA are trademarks or registered names of their respective organizations. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.
Related FormBlends Guides
These related FormBlends guides cover nearby treatment, safety, and medication-comparison questions:
- How to Get Testosterone Online Legally: The Complete Telehealth Prescription Guide for 2026
- Online Prescription for Testosterone in 2026: What's Legal, What's Safe, and What Actually Works
- Can You Get Ozempic Online? How Telehealth Prescriptions Actually Work in 2026
Ready when you are
Gonadorelin (GnRH)
Bioidentical GnRH for maintaining natural testosterone production · From $99/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.
View Gonadorelin (GnRH) →